奥翔药业(603229.SH)发布前三季度业绩，归母净利润2.07亿元，同比下降9.59%

Core Insights - The company reported a revenue of 646 million yuan for the first three quarters of 2025, representing a year-on-year decline of 6.40% [1] - The net profit attributable to the parent company was 207 million yuan, down 9.59% year-on-year [1] - The non-recurring net profit was 183 million yuan, reflecting a year-on-year decrease of 13.83% [1] - The basic earnings per share stood at 0.25 yuan [1]